Related Experiment Video
Updated: Feb 5, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
EGb761 improves the cognitive function of elderly db/db-/- diabetic mice by regulating the beclin-1 and NF-κB
Zhu-Fei Guan1,2, Xiao-Ming Zhang1, Ying-Hong Tao3
1Department of Geriatrics, National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China.
Abstract:
To assess whether EGb761 could protect elderly diabetic mice with cognitive disorders and explore the role of beclin-1-mediated autophagy in these protective effects. Two-month-old male db/db-/- mice and wild-type C57/BL6 mice were randomly divided into six groups: db/db-/- control, db/db-/- 50 mg, db/db-/- 100 mg, wild-type (WT) control, WT 50 mg, and WT 100 mg. EGb761 (50 mg/kg or 100 mg/kg of bodyweight) was given by gavage once a day for 1 month from the age of 6 months. Y-maze and social choice tests were performed at 8th months. The blood pressure was measured. The imaging changes in the brain were measured using magnetic resonance imaging (MRI). The expression and distribution of beclin-1, LC3, and NF-κB were detected using immunohistochemistry staining and western blotting. Ultrastructure alterations in the hippocampus were observed using transmission electron microscopy. Compared with WT mice, the learning ability, memory and overall cognitive function of db/db-/- mice decreased (P < 0.05), and EGb761 could significantly improve the learning and memory function of db/db-/- mice (P < 0.05). EGb761 significantly improved systolic blood pressure in db/db-/- mice (P < 0.01). In addition, fMRI-bold showed a decline in the hippocampus of mice in the db/db-/- group compared with WT. EGb761 could improve these above changes. Immunohistochemistry staining and western blotting confirmed that EGb761 significantly increased beclin-1 and reduced LC3-II/I levels in the brains of db/db-/- mice (P < 0.05). NF-κB levels were obviously higher in the db/db-/- group than that in the WT group, and EGb761 significantly reduced NF-κB levels in db/db-/- mice (P < 0.05). There was a trend of increased autophagosomes in db/db-/- mice, but EGb761 did not change obviously the number of autophagosomes. Compared with normal aged WT mice, aging db/db-/- mice had more common complications of cerebral small vessel disease and cognitive dysfunction. EGb761 could significantly improve the cognitive function of aging db/db-/- mice via a mechanism that may involve the regulation of beclin-1, LC3, and NF-κB.
Insights
EGb761, a ginkgo biloba extract, improved cognitive function and blood pressure in diabetic mice. The study suggests EGb761 may protect against cognitive decline by modulating beclin-1-mediated autophagy and NF-κB pathways.
Area of Science:
- Neuroscience
- Pharmacology
- Gerontology
Background:
- Elderly diabetic mice (db/db-/-) exhibit cognitive deficits and cerebral small vessel disease.
- Autophagy, regulated by beclin-1 and LC3, plays a role in cellular health and disease.
- NF-κB is implicated in inflammatory processes that can affect cognitive function.
Purpose of the Study:
- To evaluate the neuroprotective effects of EGb761 in elderly diabetic mice with cognitive impairment.
- To investigate the involvement of beclin-1-mediated autophagy in EGb761's protective mechanisms.
Main Methods:
- Diabetic (db/db-/-) and wild-type (WT) mice were treated with EGb761 (50 or 100 mg/kg) or vehicle.
- Cognitive function was assessed using Y-maze and social choice tests.
- Brain imaging (fMRI-BOLD), blood pressure, and molecular markers (beclin-1, LC3, NF-κB) were analyzed.
Main Results:
- EGb761 significantly improved learning, memory, and cognitive function in db/db-/- mice.
- EGb761 reduced systolic blood pressure and improved hippocampal function in fMRI-BOLD scans.
- EGb761 increased beclin-1, decreased LC3-II/I, and reduced NF-κB levels in the brains of db/db-/- mice.
Conclusions:
- EGb761 demonstrates significant cognitive-enhancing and cardioprotective effects in aging diabetic mice.
- The findings suggest EGb761's mechanism involves the modulation of beclin-1, LC3, and NF-κB pathways.
- EGb761 holds potential as a therapeutic agent for cognitive dysfunction associated with diabetes and aging.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
07:41Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Piaget's Stage 1 of Cognitive Development
Exploration...
Non-Canonical Wnt Signaling Pathways